T cell exhaustion in protozoan disease

Trends in Parasitology

Volumn 28, Issue 9, 2012, Pages 377-384

  Gigley, Jason P ^a   Bhadra, Rajarshi ^a   Moretto, Magali M ^a   Khan, Imtiaz A ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Exhaustion; Leishmania; Parasite; Plasmodium; Protozoan; T cell; Toxoplasma

Indexed keywords

CELL FUNCTION; LEISHMANIA; NONHUMAN; PARASITOSIS; PLASMODIUM; PROTOZOON; REVIEW; T LYMPHOCYTE; TOXOPLASMA GONDII;

HOST-PARASITE INTERACTIONS; HUMANS; PROTOZOAN INFECTIONS; T-LYMPHOCYTES;

LEISHMANIA SP.; PLASMODIUM SP.; PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 84865159642     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2012.07.001     Document Type: Review

References (54)

1. Lukens J.R., et al. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. J. Immunol. 2008, 180:4875-4884.
2. Betts M.R., et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006, 107:4781-4789.
3. Wherry E.J. T cell exhaustion. Nat. Immunol. 2011, 12:492-499.
4. Blackburn S.D., et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 2009, 10:29-37.
5. Wherry E.J., et al. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 2003, 77:4911-4927.
6. Angelosanto J.M., Wherry E.J. Transcription factor regulation of CD8+ T-cell memory and exhaustion. Immunol. Rev. 2010, 236:167-175.
7. Shin H., et al. A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity 2009, 31:309-320.
8. Ejrnaes M., et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 2006, 203:2461-2472.
9. Tinoco R., et al. Cell-intrinsic transforming growth factor-β signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity 2009, 31:145-157.
10. Guerra C.A., et al. Mapping the global extent of malaria in 2005. Trends Parasitol. 2006, 22:353-358.
11. Rodrigues M.M., et al. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 1991, 3:579-585.
12. Cockburn I.A., et al. Memory CD8+ T cell responses expand when antigen presentation overcomes T cell self-regulation. J. Immunol. 2008, 180:64-71.
13. Douradinha B., Doolan D.L. Harnessing immune responses against Plasmodium for rational vaccine design. Trends Parasitol. 2011, 27:274-283.
14. Borrmann S., Matuschewski K. Protective immunity against malaria by 'natural immunization': a question of dose, parasite diversity, or both?. Curr. Opin. Immunol. 2011, 23:500-508.
15. Wykes M.N. Are plasmacytoid dendritic cells the misguided sentinels of malarial immunity?. Trends Parasitol. 2012, 28:182-186.
16. Goncalves R.M., et al. CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses?. Infect. Immun. 2010, 78:4763-4772.
17. Butler N.S., et al. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat. Immunol. 2011, 13:188-195.
18. Chandele A., et al. Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii. Immunology 2010, 132:273-286.
19. Crotty S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 2011, 29:621-663.
20. Stephens R., Langhorne J. Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria. PLoS Pathog. 2010, 6:e1001208.
21. Bhadra R., et al. The CD8 T-cell road to immunotherapy of toxoplasmosis. Immunotherapy 2011, 3:789-801.
22. Gigley J.P., et al. CD8 T cells and Toxoplasma gondii: a new paradigm. J. Parasitol. Res. 2011, 2011:243796.
23. Bhadra R., et al. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9196-9201.
24. Bhadra R., et al. PD-1 mediated attrition of polyfunctional memory CD8+ T cells in chronic Toxoplasma infection. J. Infect. Dis. 2012, 206:125-134.
25. Petrovas C., et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 2006, 203:2281-2292.
26. Bhadra R., et al. Cutting edge: CD40-CD40 ligand pathway plays a critical CD8-intrinsic and -extrinsic role during rescue of exhausted CD8 T cells. J. Immunol. 2011, 187:4421-4425.
27. Kaye P., Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 2011, 9:604-615.
28. Stern J.J., et al. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J. Immunol. 1988, 140:3971-3977.
29. Muller I., et al. Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells. Infect. Immun. 1993, 61:3730-3738.
30. Belkaid Y., et al. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 2002, 168:3992-4000.
31. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002, 2:845-858.
32. de Veer M.J., et al. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 2003, 33:2822-2831.
33. Karp C.L., et al. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-γ. J. Clin. Invest. 1993, 91:1644-1648.
34. Hernandez-Ruiz J., et al. CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. PLoS Negl. Trop. Dis. 2010, 4:e871.
35. Joshi T., et al. B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections. PLoS Pathog. 2009, 5:e1000431.
36. Snyder C.M., et al. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 2008, 29:650-659.
37. Bustamante J.M., et al. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat. Med. 2008, 14:542-550.
38. Brooks D.G., et al. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20428-20433.
39. Cretney E., et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 2011, 12:304-311.
40. Bueno L.L., et al. Plasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites. PLoS ONE 2010, 5:e9623.
41. Ghalib H.W., et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 1993, 92:324-329.
42. Murphy M.L., et al. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 2001, 31:2848-2856.
43. Salhi A., et al. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J. Immunol. 2008, 180:6139-6148.
44. Murray H.W., et al. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 2002, 70:6284-6293.
45. Carvalho L.H., et al. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat. Med. 2002, 8:166-170.
46. Elsaesser H., et al. IL-21 is required to control chronic viral infection. Science 2009, 324:1569-1572.
47. Abu-Raddad L.J., et al. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006, 314:1603-1606.
48. Kao C., et al. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat. Immunol. 2011, 12:663-671.
49. Quigley M., et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat. Med. 2010, 16:1147-1151.
50. Agnellini P., et al. Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4565-4570.
51. Doolan D.L., et al. Acquired immunity to malaria. Clin. Microbiol. Rev. 2009, 22:13-36.
52. Chakravarty S., et al. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 2007, 13:1035-1041.
53. Beattie L., Kaye P.M. Leishmania-host interactions: what has imaging taught us?. Cell. Microbiol. 2011, 13:1659-1667.
54. Jin H.T., et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14733-14738.